Hangzhou Tigermed Consulting Co., Ltd
HNGZY
$3.96
-$0.14-3.38%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 85.13M | 40.90M | 46.37M | 56.36M | 133.24M |
| Total Depreciation and Amortization | 44.83M | 45.22M | 44.80M | 44.80M | 42.08M |
| Total Amortization of Deferred Charges | 5.52M | 5.70M | 5.51M | 5.51M | 4.59M |
| Total Other Non-Cash Items | 67.32M | 39.45M | 90.44M | 73.32M | 81.32M |
| Change in Net Operating Assets | -28.17M | 53.19M | -27.22M | -27.22M | -114.31M |
| Cash from Operations | 174.63M | 184.47M | 159.91M | 152.78M | 146.91M |
| Capital Expenditure | -34.98M | -35.41M | -40.64M | -49.56M | -52.61M |
| Sale of Property, Plant, and Equipment | 594.60K | 585.70K | 296.00K | 324.90K | 97.90K |
| Cash Acquisitions | -63.65M | -51.26M | -50.74M | -50.43M | -3.92M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 304.28M | 75.91M | -638.11M | -555.75M | -727.71M |
| Cash from Investing | 206.24M | -10.17M | -729.20M | -655.43M | -784.15M |
| Total Debt Issued | 1.58B | 2.87B | 3.56B | 3.38B | 3.24B |
| Total Debt Repaid | -4.17B | -4.51B | -4.27B | -4.03B | -2.86B |
| Issuance of Common Stock | 604.89M | 419.08M | 452.28M | 410.98M | 489.29M |
| Repurchase of Common Stock | -642.46M | -642.46M | -548.75M | -548.75M | -307.71M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -51.88M | -118.24M | -89.12M | -89.61M | -87.61M |
| Other Financing Activities | -116.88M | -24.58M | -366.53M | -269.50M | -689.38M |
| Cash from Financing | -432.98M | -379.93M | -251.79M | -237.17M | -105.17M |
| Foreign Exchange rate Adjustments | 2.44M | 799.90K | 404.00K | -984.60K | -4.90M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -49.67M | -204.83M | -820.68M | -740.80M | -747.30M |